Eiger Mountains
Form DEF 14A
EIGER BIOPHARMACEUTICALS, INC. filed this Form DEF 14A on 04/28/2017
Document Outline
Entire Document (672.5 KB)
Subdocument 1 - DEF 14A - DEFINITIVE PROXY STATEMENT
Page 1 - SCHEDULE 14A INFORMATION
Page 2 - NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
Page 3 - PROXY STATEMENT
Page 4 - What am I voting on?
Page 5 - How many votes do I have?
Page 6 - Beneficial Owner: Shares Registered in the Name of Broker or Bank
Page 7 - How many votes are needed to approve each proposal?
Page 8 - N/A
Page 9 - PROPOSAL 1
Page 10 - Jeffrey S. Glenn, M.D., Ph.D.
Page 11 - CLASS I DIRECTORS
Page 12 - BOARD LEADERSHIP STRUCTURE
Page 13 - Audit Committee
Page 14 - N/A
Page 15 - Report of the Audit Committee of the Board of Directors
Page 16 - Compensation Committee Interlocks and Insider Participation
Page 17 - Nominating and Corporate Governance Committee
Page 18 - STOCKHOLDER COMMUNICATIONS WITH THE BOARD OF DIRECTORS
Page 19 - PROPOSAL 2
Page 20 - Other Auditors
Page 21 - PRE-APPROVAL POLICIES AND PROCEDURES
Page 22 - EXECUTIVE OFFICERS
Page 23 - N/A
Page 24 - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
Page 25 - N/A
Page 26 - SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Page 27 - EXECUTIVE COMPENSATION
Page 28 - Outstanding Equity Awards at Fiscal Year-End
Page 29 - Employment, Severance and Change in Control Agreements
Page 30 - 1st Amendment to Employment Agreement
Page 31 - Bonus Payments in Lieu of Severance and Retention
Page 32 - Nonqualified Deferred Compensation
Page 33 - N/A
Page 34 - TRANSACTIONS WITH RELATED PERSONS
Page 35 - Eiger Subscription Agreement
Page 36 - N/A
Page 37 - HOUSEHOLDING OF PROXY MATERIALS
Page 38 - OTHER MATTERS
Page 39 - N/A
Page 40 - N/A